Mark W. Begor - 11 Feb 2022 Form 4 Insider Report for EQUIFAX INC (EFX)

Role
CEO, Director
Signature
/s/Lisa Stockard as Attorney-in-Fact
Issuer symbol
EFX
Transactions as of
11 Feb 2022
Net transactions value
$0
Form type
4
Filing time
15 Feb 2022, 16:34:40 UTC
Previous filing
04 Jan 2022
Next filing
24 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EFX Common Stock Award $0 +8,978 +18% $0.000000 58,302 11 Feb 2022 Direct F1, F2
holding EFX Common Stock 45,932 11 Feb 2022 2-Year 2021 GRAT
holding EFX Common Stock 45,933 11 Feb 2022 4-Year 2021 GRAT

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EFX Stock Option/Right to Buy Award $0 +19,649 $0.000000 19,649 11 Feb 2022 Common Stock 19,649 $247.50 Direct F3
transaction EFX Stock Option/Right to Buy Award $0 +17,522 $0.000000 17,522 11 Feb 2022 Common Stock 17,522 $270.50 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on 2/11/2025.
F2 Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.
F3 Annual equity grant pursuant to the Company's long-term incentive plan. The option vests 100% on December 31, 2025.